Autism Science Foundation: Pre- and Post-Doctoral Fellowships, & Post-Undergraduate Fellowships
Grant Amount: Between $30,000 and $50,000
Deadline: December 8, 2023
Additional Information -
The Autism Science Foundation regularly awards grants and fellowships to autism researchers studying a variety of issues aimed at finding solutions for people with autism.
One year pre-doctoral and post-doctoral, and two year post-undergraduate fellowships are available for qualified applicants interested in autism research. The foundations seeks proposals that seek an understanding of the biological mechanisms of brain development, promote earlier detection, develop new personalized treatment approaches, and improve the quality of life for those with autism.
All scientists funded through this mechanism will participate in ASF’s “Open Access Publications” program, through which peer-reviewed, published research funded by the Autism Science Foundation is made available to the public free of charge via PubMed through a collaboration between the Health Research Alliance, ASF, and the National Libraries of Medicine.
Please contact Lynn Wong (Lynn.Wong@hsc.utah.edu) if you are interested in applying to this opportunity.
Crohn's and Colitis Foundation: Litwin IBD Pioneers Initiative Grants
Grant Amount: Between Up to $130,000
Deadline: Letter of Intent Due November 16, 2023
Additional Information -
The Litwin IBD Pioneers initiative, formerly known as the Broad Medical Research Program at the Crohn’s & Colitis Foundation, supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data.
Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is open to investigators from other disciplines new to the IBD field, as well as countries outside the United States.
Grant proposals are selected for funding based on their scientific strength, innovation and relevance to IBD diagnosis, therapy or prevention. Preference is given to proposals for work conducted with patients or patient material and with strong potential for clinical applicability in the foreseeable future.
Please contact Sara Salmon if you are interested in applying to this opportunity.
Foundation Fighting Blindness: Scientific Grants and Awards Programs (multiple opportunities)
The Foundation Fighting Blindness’ Grants and Awards Programs annually support basic, laboratory-based early translational, clinical studies, and pre-clinical research applicable to a broad range of inherited retinal degenerative diseases. The goal is to find the causes, preventions, treatments, and cures for retinitis pigmentosa, macular degeneration, and the entire spectrum of retinal degenerative diseases.
The foundation is accepting letters of intent for the following:
Individual Investigator Research/Clinical Innovation Awards (IIRA/CIA)Individual
Amount: $300,000 over three years
LOI deadline: October 26, 2023
Investigator Research Awards are designed to concentrate research in areas with the greatest potential to move toward treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration. The Foundation Fighting Blindness will also award up to four Clinical Innovation Awards to advance options for endpoints in IRD clinical trials that might be accepted by regulatory agencies for improving IRD patients’ conditions or slowing disease progression.
Free Family AMD Research Award
Amount: $600,000 over three years
LOI deadline: October 5, 2023
The Free Family Age-Related Macular Degeneration (AMD) Award funding strives to find solutions for early, dry AMD. Efforts are concentrated on determining the strength of pathophysiologic pathways and their interactions with other pathways to cause AMD lesions of early AMD pathobiology. This award will include two PIs who are jointly responsible for the scientific and technical direction of the project, thereby leveraging a team science approach. Multidisciplinary projects are highly encouraged. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.
Program Project Award (PPA)
Amount: Up to $2.5 Million, up to over five years ($500k/year over 5 years)
LOI deadline: October 12, 2023
This award engages cross-disciplinary investigators to drive collaborative retinal degenerative disease research efforts. The PPA enables studies that are too large or technically complex for a single investigator to undertake in a reasonable amount of time and to address current knowledge and/or therapeutic gaps. The effort is unified around a single, well-articulated research hypothesis and clearly defined milestones relevant to the Foundation’s mission. The PPA award address knowledge gaps or therapeutic goals identified by The Foundation or an equally significant gap or goal approved by the Foundation. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.
Please contact Gwen Allouch (gwen.allouch@hsc.utah.edu) if you are interested in applying to these opportunities.
Health Effects Institute: Assessing Changes in Exposures and Health Outcomes in Historically Marginalized and Environmentally Overburdened Communities from Air Quality Actions, Programs, or Other Interventions
Grant Amount: Between $2 and $3 million will be available for this RFA.
HEI expects to fund a small number of studies (2 to 3 years in duration).
Deadline: February 9, 2024
Additional Information -
This RFA seeks to fund studies that assess the effects of actions, programs, or other interventions on ambient or indoor air pollution exposure, health outcomes, or both in historically marginalized and environmentally overburdened urban or rural communities (hereafter referred to as “historically marginalized communities”) in the United States.
The overall objective of this RFA is to fund studies that evaluate actions, programs, or other interventions in the United States at the national, regional, tribal, state, or local level that have affected or have the potential to affect air quality, exposure, or health outcomes in historically marginalized communities.
Areas of interest include the following:
- Studies that evaluate past or current actions, programs, other interventions at the national, regional, tribal, state, or local level that were specifically designed and implemented to reduce exposures to ambient or indoor air pollutants and improve health in historically marginalized communities.
- Studies that evaluate past or current actions, programs, or other interventions at the national, regional, tribal, state, or local level that were specifically designed and implemented to reduce exposures to ambient or indoor air pollutants and improve health in the general population that might have benefited historically marginalized communities, had an inequitable distribution of benefits among communities, or worsened conditions in historically marginalized communities (e.g., have had unintended consequences).
- Studies that evaluate past, current, or proposed actions, programs, or other interventions at the national, regional, tribal, state, or local level that were or are designed or implemented to achieve goals other than decreasing air pollution exposures but indirectly affect exposures to ambient or indoor air in the general population. The actions might have benefited historically marginalized communities, had an inequitable distribution of benefits among communities, or worsened conditions in historically marginalized communities.
- Studies that prospectively evaluate the expected health or exposure changes in relation to proposed actions, programs, or other interventions at the national, tribal, state, or local level that are intended to reduce inequities in exposures or have the potential to affect inequities in exposures to air pollutants in historically marginalized communities. Studies should be designed to directly inform development and implementation of the proposed action under study.
Please contact Sara Salmon if you are interested in applying to this opportunity.